Global Pharmaceutical CDMO Services Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Pharmaceutical CDMO Services market size was valued at US$ million in 2023. With growing demand in downstream market, the Pharmaceutical CDMO Services is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Pharmaceutical CDMO Services market. Pharmaceutical CDMO Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmaceutical CDMO Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmaceutical CDMO Services market.
A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmaceutical CDMO Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmaceutical CDMO Services market. It may include historical data, market segmentation by Type (e.g., Drug Substance Development and Manufacturing, Specialized Services), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmaceutical CDMO Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmaceutical CDMO Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmaceutical CDMO Services industry. This include advancements in Pharmaceutical CDMO Services technology, Pharmaceutical CDMO Services new entrants, Pharmaceutical CDMO Services new investment, and other innovations that are shaping the future of Pharmaceutical CDMO Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmaceutical CDMO Services market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmaceutical CDMO Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmaceutical CDMO Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmaceutical CDMO Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmaceutical CDMO Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmaceutical CDMO Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmaceutical CDMO Services market.
Market Segmentation:
Pharmaceutical CDMO Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Pharmaceutical CDMO Services market size was valued at US$ million in 2023. With growing demand in downstream market, the Pharmaceutical CDMO Services is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Pharmaceutical CDMO Services market. Pharmaceutical CDMO Services are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pharmaceutical CDMO Services. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pharmaceutical CDMO Services market.
A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Pharmaceutical CDMO Services market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pharmaceutical CDMO Services market. It may include historical data, market segmentation by Type (e.g., Drug Substance Development and Manufacturing, Specialized Services), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pharmaceutical CDMO Services market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pharmaceutical CDMO Services market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pharmaceutical CDMO Services industry. This include advancements in Pharmaceutical CDMO Services technology, Pharmaceutical CDMO Services new entrants, Pharmaceutical CDMO Services new investment, and other innovations that are shaping the future of Pharmaceutical CDMO Services.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pharmaceutical CDMO Services market. It includes factors influencing customer ' purchasing decisions, preferences for Pharmaceutical CDMO Services product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pharmaceutical CDMO Services market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pharmaceutical CDMO Services market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pharmaceutical CDMO Services market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pharmaceutical CDMO Services industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pharmaceutical CDMO Services market.
Market Segmentation:
Pharmaceutical CDMO Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Drug Substance Development and Manufacturing
- Specialized Services
- Lab-based Services
- Innovative Medicine
- Patented Drug
- Patent Expired Drug
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Recipharm AB
- AMRI Global
- Patheon N.V.
- Aenova Group
- Catalent, Inc.
- Amatsigroup
- WuXi AppTec Group
- Strides Pharma Science Limited
- Piramal Pharma Solutions
- Siegfried Ltd
- Fareva Group
- FAMAR Health Care Services
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Services Market Size 2019-2030
2.1.2 Pharmaceutical CDMO Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmaceutical CDMO Services Segment by Type
2.2.1 Drug Substance Development and Manufacturing
2.2.2 Specialized Services
2.2.3 Lab-based Services
2.3 Pharmaceutical CDMO Services Market Size by Type
2.3.1 Pharmaceutical CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
2.4 Pharmaceutical CDMO Services Segment by Application
2.4.1 Innovative Medicine
2.4.2 Patented Drug
2.4.3 Patent Expired Drug
2.5 Pharmaceutical CDMO Services Market Size by Application
2.5.1 Pharmaceutical CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
3 PHARMACEUTICAL CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Services Market Size Market Share by Players
3.1.1 Global Pharmaceutical CDMO Services Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO SERVICES BY REGIONS
4.1 Pharmaceutical CDMO Services Market Size by Regions (2019-2024)
4.2 Americas Pharmaceutical CDMO Services Market Size Growth (2019-2024)
4.3 APAC Pharmaceutical CDMO Services Market Size Growth (2019-2024)
4.4 Europe Pharmaceutical CDMO Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmaceutical CDMO Services Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Services Market Size by Country (2019-2024)
5.2 Americas Pharmaceutical CDMO Services Market Size by Type (2019-2024)
5.3 Americas Pharmaceutical CDMO Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Services Market Size by Region (2019-2024)
6.2 APAC Pharmaceutical CDMO Services Market Size by Type (2019-2024)
6.3 APAC Pharmaceutical CDMO Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO Services by Country (2019-2024)
7.2 Europe Pharmaceutical CDMO Services Market Size by Type (2019-2024)
7.3 Europe Pharmaceutical CDMO Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO Services by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO SERVICES MARKET FORECAST
10.1 Global Pharmaceutical CDMO Services Forecast by Regions (2025-2030)
10.1.1 Global Pharmaceutical CDMO Services Forecast by Regions (2025-2030)
10.1.2 Americas Pharmaceutical CDMO Services Forecast
10.1.3 APAC Pharmaceutical CDMO Services Forecast
10.1.4 Europe Pharmaceutical CDMO Services Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Services Forecast
10.2 Americas Pharmaceutical CDMO Services Forecast by Country (2025-2030)
10.2.1 United States Pharmaceutical CDMO Services Market Forecast
10.2.2 Canada Pharmaceutical CDMO Services Market Forecast
10.2.3 Mexico Pharmaceutical CDMO Services Market Forecast
10.2.4 Brazil Pharmaceutical CDMO Services Market Forecast
10.3 APAC Pharmaceutical CDMO Services Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical CDMO Services Market Forecast
10.3.2 Japan Pharmaceutical CDMO Services Market Forecast
10.3.3 Korea Pharmaceutical CDMO Services Market Forecast
10.3.4 Southeast Asia Pharmaceutical CDMO Services Market Forecast
10.3.5 India Pharmaceutical CDMO Services Market Forecast
10.3.6 Australia Pharmaceutical CDMO Services Market Forecast
10.4 Europe Pharmaceutical CDMO Services Forecast by Country (2025-2030)
10.4.1 Germany Pharmaceutical CDMO Services Market Forecast
10.4.2 France Pharmaceutical CDMO Services Market Forecast
10.4.3 UK Pharmaceutical CDMO Services Market Forecast
10.4.4 Italy Pharmaceutical CDMO Services Market Forecast
10.4.5 Russia Pharmaceutical CDMO Services Market Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Services Forecast by Region (2025-2030)
10.5.1 Egypt Pharmaceutical CDMO Services Market Forecast
10.5.2 South Africa Pharmaceutical CDMO Services Market Forecast
10.5.3 Israel Pharmaceutical CDMO Services Market Forecast
10.5.4 Turkey Pharmaceutical CDMO Services Market Forecast
10.5.5 GCC Countries Pharmaceutical CDMO Services Market Forecast
10.6 Global Pharmaceutical CDMO Services Forecast by Type (2025-2030)
10.7 Global Pharmaceutical CDMO Services Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Recipharm AB
11.1.1 Recipharm AB Company Information
11.1.2 Recipharm AB Pharmaceutical CDMO Services Product Offered
11.1.3 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Recipharm AB Main Business Overview
11.1.5 Recipharm AB Latest Developments
11.2 AMRI Global
11.2.1 AMRI Global Company Information
11.2.2 AMRI Global Pharmaceutical CDMO Services Product Offered
11.2.3 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AMRI Global Main Business Overview
11.2.5 AMRI Global Latest Developments
11.3 Patheon N.V.
11.3.1 Patheon N.V. Company Information
11.3.2 Patheon N.V. Pharmaceutical CDMO Services Product Offered
11.3.3 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Patheon N.V. Main Business Overview
11.3.5 Patheon N.V. Latest Developments
11.4 Aenova Group
11.4.1 Aenova Group Company Information
11.4.2 Aenova Group Pharmaceutical CDMO Services Product Offered
11.4.3 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aenova Group Main Business Overview
11.4.5 Aenova Group Latest Developments
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Information
11.5.2 Catalent, Inc. Pharmaceutical CDMO Services Product Offered
11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Catalent, Inc. Main Business Overview
11.5.5 Catalent, Inc. Latest Developments
11.6 Amatsigroup
11.6.1 Amatsigroup Company Information
11.6.2 Amatsigroup Pharmaceutical CDMO Services Product Offered
11.6.3 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amatsigroup Main Business Overview
11.6.5 Amatsigroup Latest Developments
11.7 WuXi AppTec Group
11.7.1 WuXi AppTec Group Company Information
11.7.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 WuXi AppTec Group Main Business Overview
11.7.5 WuXi AppTec Group Latest Developments
11.8 Strides Pharma Science Limited
11.8.1 Strides Pharma Science Limited Company Information
11.8.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Strides Pharma Science Limited Main Business Overview
11.8.5 Strides Pharma Science Limited Latest Developments
11.9 Piramal Pharma Solutions
11.9.1 Piramal Pharma Solutions Company Information
11.9.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Piramal Pharma Solutions Main Business Overview
11.9.5 Piramal Pharma Solutions Latest Developments
11.10 Siegfried Ltd
11.10.1 Siegfried Ltd Company Information
11.10.2 Siegfried Ltd Pharmaceutical CDMO Services Product Offered
11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Siegfried Ltd Main Business Overview
11.10.5 Siegfried Ltd Latest Developments
11.11 Fareva Group
11.11.1 Fareva Group Company Information
11.11.2 Fareva Group Pharmaceutical CDMO Services Product Offered
11.11.3 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Fareva Group Main Business Overview
11.11.5 Fareva Group Latest Developments
11.12 FAMAR Health Care Services
11.12.1 FAMAR Health Care Services Company Information
11.12.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 FAMAR Health Care Services Main Business Overview
11.12.5 FAMAR Health Care Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical CDMO Services Market Size 2019-2030
2.1.2 Pharmaceutical CDMO Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Pharmaceutical CDMO Services Segment by Type
2.2.1 Drug Substance Development and Manufacturing
2.2.2 Specialized Services
2.2.3 Lab-based Services
2.3 Pharmaceutical CDMO Services Market Size by Type
2.3.1 Pharmaceutical CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
2.4 Pharmaceutical CDMO Services Segment by Application
2.4.1 Innovative Medicine
2.4.2 Patented Drug
2.4.3 Patent Expired Drug
2.5 Pharmaceutical CDMO Services Market Size by Application
2.5.1 Pharmaceutical CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
3 PHARMACEUTICAL CDMO SERVICES MARKET SIZE BY PLAYER
3.1 Pharmaceutical CDMO Services Market Size Market Share by Players
3.1.1 Global Pharmaceutical CDMO Services Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHARMACEUTICAL CDMO SERVICES BY REGIONS
4.1 Pharmaceutical CDMO Services Market Size by Regions (2019-2024)
4.2 Americas Pharmaceutical CDMO Services Market Size Growth (2019-2024)
4.3 APAC Pharmaceutical CDMO Services Market Size Growth (2019-2024)
4.4 Europe Pharmaceutical CDMO Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Pharmaceutical CDMO Services Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Pharmaceutical CDMO Services Market Size by Country (2019-2024)
5.2 Americas Pharmaceutical CDMO Services Market Size by Type (2019-2024)
5.3 Americas Pharmaceutical CDMO Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical CDMO Services Market Size by Region (2019-2024)
6.2 APAC Pharmaceutical CDMO Services Market Size by Type (2019-2024)
6.3 APAC Pharmaceutical CDMO Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Pharmaceutical CDMO Services by Country (2019-2024)
7.2 Europe Pharmaceutical CDMO Services Market Size by Type (2019-2024)
7.3 Europe Pharmaceutical CDMO Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical CDMO Services by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHARMACEUTICAL CDMO SERVICES MARKET FORECAST
10.1 Global Pharmaceutical CDMO Services Forecast by Regions (2025-2030)
10.1.1 Global Pharmaceutical CDMO Services Forecast by Regions (2025-2030)
10.1.2 Americas Pharmaceutical CDMO Services Forecast
10.1.3 APAC Pharmaceutical CDMO Services Forecast
10.1.4 Europe Pharmaceutical CDMO Services Forecast
10.1.5 Middle East & Africa Pharmaceutical CDMO Services Forecast
10.2 Americas Pharmaceutical CDMO Services Forecast by Country (2025-2030)
10.2.1 United States Pharmaceutical CDMO Services Market Forecast
10.2.2 Canada Pharmaceutical CDMO Services Market Forecast
10.2.3 Mexico Pharmaceutical CDMO Services Market Forecast
10.2.4 Brazil Pharmaceutical CDMO Services Market Forecast
10.3 APAC Pharmaceutical CDMO Services Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical CDMO Services Market Forecast
10.3.2 Japan Pharmaceutical CDMO Services Market Forecast
10.3.3 Korea Pharmaceutical CDMO Services Market Forecast
10.3.4 Southeast Asia Pharmaceutical CDMO Services Market Forecast
10.3.5 India Pharmaceutical CDMO Services Market Forecast
10.3.6 Australia Pharmaceutical CDMO Services Market Forecast
10.4 Europe Pharmaceutical CDMO Services Forecast by Country (2025-2030)
10.4.1 Germany Pharmaceutical CDMO Services Market Forecast
10.4.2 France Pharmaceutical CDMO Services Market Forecast
10.4.3 UK Pharmaceutical CDMO Services Market Forecast
10.4.4 Italy Pharmaceutical CDMO Services Market Forecast
10.4.5 Russia Pharmaceutical CDMO Services Market Forecast
10.5 Middle East & Africa Pharmaceutical CDMO Services Forecast by Region (2025-2030)
10.5.1 Egypt Pharmaceutical CDMO Services Market Forecast
10.5.2 South Africa Pharmaceutical CDMO Services Market Forecast
10.5.3 Israel Pharmaceutical CDMO Services Market Forecast
10.5.4 Turkey Pharmaceutical CDMO Services Market Forecast
10.5.5 GCC Countries Pharmaceutical CDMO Services Market Forecast
10.6 Global Pharmaceutical CDMO Services Forecast by Type (2025-2030)
10.7 Global Pharmaceutical CDMO Services Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Recipharm AB
11.1.1 Recipharm AB Company Information
11.1.2 Recipharm AB Pharmaceutical CDMO Services Product Offered
11.1.3 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Recipharm AB Main Business Overview
11.1.5 Recipharm AB Latest Developments
11.2 AMRI Global
11.2.1 AMRI Global Company Information
11.2.2 AMRI Global Pharmaceutical CDMO Services Product Offered
11.2.3 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AMRI Global Main Business Overview
11.2.5 AMRI Global Latest Developments
11.3 Patheon N.V.
11.3.1 Patheon N.V. Company Information
11.3.2 Patheon N.V. Pharmaceutical CDMO Services Product Offered
11.3.3 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Patheon N.V. Main Business Overview
11.3.5 Patheon N.V. Latest Developments
11.4 Aenova Group
11.4.1 Aenova Group Company Information
11.4.2 Aenova Group Pharmaceutical CDMO Services Product Offered
11.4.3 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aenova Group Main Business Overview
11.4.5 Aenova Group Latest Developments
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Information
11.5.2 Catalent, Inc. Pharmaceutical CDMO Services Product Offered
11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Catalent, Inc. Main Business Overview
11.5.5 Catalent, Inc. Latest Developments
11.6 Amatsigroup
11.6.1 Amatsigroup Company Information
11.6.2 Amatsigroup Pharmaceutical CDMO Services Product Offered
11.6.3 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Amatsigroup Main Business Overview
11.6.5 Amatsigroup Latest Developments
11.7 WuXi AppTec Group
11.7.1 WuXi AppTec Group Company Information
11.7.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 WuXi AppTec Group Main Business Overview
11.7.5 WuXi AppTec Group Latest Developments
11.8 Strides Pharma Science Limited
11.8.1 Strides Pharma Science Limited Company Information
11.8.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Strides Pharma Science Limited Main Business Overview
11.8.5 Strides Pharma Science Limited Latest Developments
11.9 Piramal Pharma Solutions
11.9.1 Piramal Pharma Solutions Company Information
11.9.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Piramal Pharma Solutions Main Business Overview
11.9.5 Piramal Pharma Solutions Latest Developments
11.10 Siegfried Ltd
11.10.1 Siegfried Ltd Company Information
11.10.2 Siegfried Ltd Pharmaceutical CDMO Services Product Offered
11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Siegfried Ltd Main Business Overview
11.10.5 Siegfried Ltd Latest Developments
11.11 Fareva Group
11.11.1 Fareva Group Company Information
11.11.2 Fareva Group Pharmaceutical CDMO Services Product Offered
11.11.3 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Fareva Group Main Business Overview
11.11.5 Fareva Group Latest Developments
11.12 FAMAR Health Care Services
11.12.1 FAMAR Health Care Services Company Information
11.12.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 FAMAR Health Care Services Main Business Overview
11.12.5 FAMAR Health Care Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical CDMO Services Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drug Substance Development and Manufacturing
Table 3. Major Players of Specialized Services
Table 4. Major Players of Lab-based Services
Table 5. Pharmaceutical CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 8. Pharmaceutical CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 11. Global Pharmaceutical CDMO Services Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Pharmaceutical CDMO Services Revenue Market Share by Player (2019-2024)
Table 13. Pharmaceutical CDMO Services Key Players Head office and Products Offered
Table 14. Pharmaceutical CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmaceutical CDMO Services Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Pharmaceutical CDMO Services Market Size Market Share by Regions (2019-2024)
Table 19. Global Pharmaceutical CDMO Services Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Pharmaceutical CDMO Services Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Pharmaceutical CDMO Services Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Pharmaceutical CDMO Services Market Size Market Share by Country (2019-2024)
Table 23. Americas Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 25. Americas Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 27. APAC Pharmaceutical CDMO Services Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Pharmaceutical CDMO Services Market Size Market Share by Region (2019-2024)
Table 29. APAC Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 31. APAC Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 33. Europe Pharmaceutical CDMO Services Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Pharmaceutical CDMO Services Market Size Market Share by Country (2019-2024)
Table 35. Europe Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 37. Europe Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Pharmaceutical CDMO Services Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO Services
Table 46. Key Market Challenges & Risks of Pharmaceutical CDMO Services
Table 47. Key Industry Trends of Pharmaceutical CDMO Services
Table 48. Global Pharmaceutical CDMO Services Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Pharmaceutical CDMO Services Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Pharmaceutical CDMO Services Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Recipharm AB Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 53. Recipharm AB Pharmaceutical CDMO Services Product Offered
Table 54. Recipharm AB Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Recipharm AB Main Business
Table 56. Recipharm AB Latest Developments
Table 57. AMRI Global Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 58. AMRI Global Pharmaceutical CDMO Services Product Offered
Table 59. AMRI Global Main Business
Table 60. AMRI Global Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. AMRI Global Latest Developments
Table 62. Patheon N.V. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 63. Patheon N.V. Pharmaceutical CDMO Services Product Offered
Table 64. Patheon N.V. Main Business
Table 65. Patheon N.V. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Patheon N.V. Latest Developments
Table 67. Aenova Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 68. Aenova Group Pharmaceutical CDMO Services Product Offered
Table 69. Aenova Group Main Business
Table 70. Aenova Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Aenova Group Latest Developments
Table 72. Catalent, Inc. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 73. Catalent, Inc. Pharmaceutical CDMO Services Product Offered
Table 74. Catalent, Inc. Main Business
Table 75. Catalent, Inc. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Catalent, Inc. Latest Developments
Table 77. Amatsigroup Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 78. Amatsigroup Pharmaceutical CDMO Services Product Offered
Table 79. Amatsigroup Main Business
Table 80. Amatsigroup Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Amatsigroup Latest Developments
Table 82. WuXi AppTec Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 83. WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
Table 84. WuXi AppTec Group Main Business
Table 85. WuXi AppTec Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. WuXi AppTec Group Latest Developments
Table 87. Strides Pharma Science Limited Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 88. Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
Table 89. Strides Pharma Science Limited Main Business
Table 90. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Strides Pharma Science Limited Latest Developments
Table 92. Piramal Pharma Solutions Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 93. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
Table 94. Piramal Pharma Solutions Main Business
Table 95. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Piramal Pharma Solutions Latest Developments
Table 97. Siegfried Ltd Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 98. Siegfried Ltd Pharmaceutical CDMO Services Product Offered
Table 99. Siegfried Ltd Main Business
Table 100. Siegfried Ltd Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Siegfried Ltd Latest Developments
Table 102. Fareva Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 103. Fareva Group Pharmaceutical CDMO Services Product Offered
Table 104. Fareva Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Fareva Group Main Business
Table 106. Fareva Group Latest Developments
Table 107. FAMAR Health Care Services Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 108. FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
Table 109. FAMAR Health Care Services Main Business
Table 110. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. FAMAR Health Care Services Latest Developments
Table 1. Pharmaceutical CDMO Services Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Drug Substance Development and Manufacturing
Table 3. Major Players of Specialized Services
Table 4. Major Players of Lab-based Services
Table 5. Pharmaceutical CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 8. Pharmaceutical CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 11. Global Pharmaceutical CDMO Services Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Pharmaceutical CDMO Services Revenue Market Share by Player (2019-2024)
Table 13. Pharmaceutical CDMO Services Key Players Head office and Products Offered
Table 14. Pharmaceutical CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmaceutical CDMO Services Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Pharmaceutical CDMO Services Market Size Market Share by Regions (2019-2024)
Table 19. Global Pharmaceutical CDMO Services Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Pharmaceutical CDMO Services Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Pharmaceutical CDMO Services Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Pharmaceutical CDMO Services Market Size Market Share by Country (2019-2024)
Table 23. Americas Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 25. Americas Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 27. APAC Pharmaceutical CDMO Services Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Pharmaceutical CDMO Services Market Size Market Share by Region (2019-2024)
Table 29. APAC Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 31. APAC Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 33. Europe Pharmaceutical CDMO Services Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Pharmaceutical CDMO Services Market Size Market Share by Country (2019-2024)
Table 35. Europe Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 37. Europe Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Pharmaceutical CDMO Services Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Pharmaceutical CDMO Services
Table 46. Key Market Challenges & Risks of Pharmaceutical CDMO Services
Table 47. Key Industry Trends of Pharmaceutical CDMO Services
Table 48. Global Pharmaceutical CDMO Services Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Pharmaceutical CDMO Services Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Pharmaceutical CDMO Services Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Recipharm AB Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 53. Recipharm AB Pharmaceutical CDMO Services Product Offered
Table 54. Recipharm AB Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Recipharm AB Main Business
Table 56. Recipharm AB Latest Developments
Table 57. AMRI Global Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 58. AMRI Global Pharmaceutical CDMO Services Product Offered
Table 59. AMRI Global Main Business
Table 60. AMRI Global Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. AMRI Global Latest Developments
Table 62. Patheon N.V. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 63. Patheon N.V. Pharmaceutical CDMO Services Product Offered
Table 64. Patheon N.V. Main Business
Table 65. Patheon N.V. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Patheon N.V. Latest Developments
Table 67. Aenova Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 68. Aenova Group Pharmaceutical CDMO Services Product Offered
Table 69. Aenova Group Main Business
Table 70. Aenova Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Aenova Group Latest Developments
Table 72. Catalent, Inc. Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 73. Catalent, Inc. Pharmaceutical CDMO Services Product Offered
Table 74. Catalent, Inc. Main Business
Table 75. Catalent, Inc. Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Catalent, Inc. Latest Developments
Table 77. Amatsigroup Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 78. Amatsigroup Pharmaceutical CDMO Services Product Offered
Table 79. Amatsigroup Main Business
Table 80. Amatsigroup Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Amatsigroup Latest Developments
Table 82. WuXi AppTec Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 83. WuXi AppTec Group Pharmaceutical CDMO Services Product Offered
Table 84. WuXi AppTec Group Main Business
Table 85. WuXi AppTec Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. WuXi AppTec Group Latest Developments
Table 87. Strides Pharma Science Limited Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 88. Strides Pharma Science Limited Pharmaceutical CDMO Services Product Offered
Table 89. Strides Pharma Science Limited Main Business
Table 90. Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Strides Pharma Science Limited Latest Developments
Table 92. Piramal Pharma Solutions Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 93. Piramal Pharma Solutions Pharmaceutical CDMO Services Product Offered
Table 94. Piramal Pharma Solutions Main Business
Table 95. Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Piramal Pharma Solutions Latest Developments
Table 97. Siegfried Ltd Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 98. Siegfried Ltd Pharmaceutical CDMO Services Product Offered
Table 99. Siegfried Ltd Main Business
Table 100. Siegfried Ltd Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Siegfried Ltd Latest Developments
Table 102. Fareva Group Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 103. Fareva Group Pharmaceutical CDMO Services Product Offered
Table 104. Fareva Group Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Fareva Group Main Business
Table 106. Fareva Group Latest Developments
Table 107. FAMAR Health Care Services Details, Company Type, Pharmaceutical CDMO Services Area Served and Its Competitors
Table 108. FAMAR Health Care Services Pharmaceutical CDMO Services Product Offered
Table 109. FAMAR Health Care Services Main Business
Table 110. FAMAR Health Care Services Pharmaceutical CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. FAMAR Health Care Services Latest Developments
LIST OF FIGURES
Figure 1. Pharmaceutical CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Services Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmaceutical CDMO Services Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2023)
Figure 8. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmaceutical CDMO Services Market Size Market Share by Type in 2023
Figure 10. Pharmaceutical CDMO Services in Innovative Medicine
Figure 11. Global Pharmaceutical CDMO Services Market: Innovative Medicine (2019-2024) & ($ Millions)
Figure 12. Pharmaceutical CDMO Services in Patented Drug
Figure 13. Global Pharmaceutical CDMO Services Market: Patented Drug (2019-2024) & ($ Millions)
Figure 14. Pharmaceutical CDMO Services in Patent Expired Drug
Figure 15. Global Pharmaceutical CDMO Services Market: Patent Expired Drug (2019-2024) & ($ Millions)
Figure 16. Global Pharmaceutical CDMO Services Market Size Market Share by Application in 2023
Figure 17. Global Pharmaceutical CDMO Services Revenue Market Share by Player in 2023
Figure 18. Global Pharmaceutical CDMO Services Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 20. APAC Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 21. Europe Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 23. Americas Pharmaceutical CDMO Services Value Market Share by Country in 2023
Figure 24. United States Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Pharmaceutical CDMO Services Market Size Market Share by Region in 2023
Figure 29. APAC Pharmaceutical CDMO Services Market Size Market Share by Type in 2023
Figure 30. APAC Pharmaceutical CDMO Services Market Size Market Share by Application in 2023
Figure 31. China Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Pharmaceutical CDMO Services Market Size Market Share by Country in 2023
Figure 38. Europe Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Figure 39. Europe Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Figure 40. Germany Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 54. APAC Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 55. Europe Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 57. United States Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 58. Canada Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 61. China Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 62. Japan Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 63. Korea Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 65. India Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 66. Australia Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 67. Germany Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 68. France Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 69. UK Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 70. Italy Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 71. Russia Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 72. Spain Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 75. Israel Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 78. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Pharmaceutical CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmaceutical CDMO Services Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Pharmaceutical CDMO Services Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2023)
Figure 8. Pharmaceutical CDMO Services Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Pharmaceutical CDMO Services Market Size Market Share by Type in 2023
Figure 10. Pharmaceutical CDMO Services in Innovative Medicine
Figure 11. Global Pharmaceutical CDMO Services Market: Innovative Medicine (2019-2024) & ($ Millions)
Figure 12. Pharmaceutical CDMO Services in Patented Drug
Figure 13. Global Pharmaceutical CDMO Services Market: Patented Drug (2019-2024) & ($ Millions)
Figure 14. Pharmaceutical CDMO Services in Patent Expired Drug
Figure 15. Global Pharmaceutical CDMO Services Market: Patent Expired Drug (2019-2024) & ($ Millions)
Figure 16. Global Pharmaceutical CDMO Services Market Size Market Share by Application in 2023
Figure 17. Global Pharmaceutical CDMO Services Revenue Market Share by Player in 2023
Figure 18. Global Pharmaceutical CDMO Services Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 20. APAC Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 21. Europe Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Pharmaceutical CDMO Services Market Size 2019-2024 ($ Millions)
Figure 23. Americas Pharmaceutical CDMO Services Value Market Share by Country in 2023
Figure 24. United States Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Pharmaceutical CDMO Services Market Size Market Share by Region in 2023
Figure 29. APAC Pharmaceutical CDMO Services Market Size Market Share by Type in 2023
Figure 30. APAC Pharmaceutical CDMO Services Market Size Market Share by Application in 2023
Figure 31. China Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Pharmaceutical CDMO Services Market Size Market Share by Country in 2023
Figure 38. Europe Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Figure 39. Europe Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Figure 40. Germany Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Pharmaceutical CDMO Services Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Pharmaceutical CDMO Services Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 54. APAC Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 55. Europe Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 57. United States Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 58. Canada Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 61. China Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 62. Japan Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 63. Korea Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 65. India Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 66. Australia Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 67. Germany Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 68. France Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 69. UK Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 70. Italy Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 71. Russia Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 72. Spain Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 75. Israel Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Pharmaceutical CDMO Services Market Size 2025-2030 ($ Millions)
Figure 78. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Pharmaceutical CDMO Services Market Size Market Share Forecast by Application (2025-2030)
